SSGJ-612

Resumen de Ensayos Clínicos

2 ensayos encontrados
Sobre SSGJ-612

Se está recopilando información detallada sobre este medicamento.

Categoría Otros Medicamentos
2
Total Ensayos
2
Reclutando
0
Activo
0
Completado
180
Inscripción Total
1
Países
Centros activos para SSGJ-612
Centros reclutando 1 países
Fase:
SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors
NCT07646626 Fase 2 Reclutando 150 pacientes
Inicio: Jul 2026
Fin: Oct 2028
Intervencional
Medicamentos: SSGJ-612 SSGJ-705
This study was an open-label phase Ⅱ study to evaluate the safety and efficacy of SSGJ-705 Plus SSGJ-612 ± Chemotherapy in patients with advanced HER2-Expressing Solid Tumors.
China
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
NCT07032298 Fase 1 Reclutando 30 pacientes
Inicio: Jul 2025
Fin: Jun 2026
Intervencional
Medicamentos: SSGJ-612
This study is an open-label phase I study to evaluate the safety, pharmacokinetics, and antitumor activity of SSGJ-612 in patients with advanced malignant solid tumors expressing HER2.
China
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
Volver al Glosario Ver Todos los Ensayos Filtrar Reclutando